| Income Statement |
| Total Revenue | 6.90M |
|
| Revenues (USD) | 6.90M |
| Cost of Revenue | 2.33M |
| Gross Profit | 4.58M |
| Operating Expenses | 2.79M |
| Research and Development Expense | 648.30K |
| Selling, General and Administrative Expense | 2.14M |
| Operating Income | 1.79M |
| Income Tax Expense | 435.84K |
| Net Income | 1.70M |
| Net Income Common Stock | 1.70M |
| Net Income Common Stock (USD) | 1.70M |
| Consolidated Income | 1.70M |
| Earnings per Basic Share | 0.15 |
| Earnings per Basic Share (USD) | 0.15 |
| Earnings per Diluted Share | 0.15 |
| Earning Before Interest & Taxes (EBIT) | 2.13M |
| Earning Before Interest & Taxes (USD) | 2.13M |
| Weighted Average Shares | 11.27M |
| Weighted Average Shares Diluted | 11.29M |
| Balance Sheet |
| Cash and Equivalents | 30.62M |
| Cash and Equivalents (USD) | 30.62M |
| Trade and Non-Trade Receivables | 7.33M |
| Current Assets | 52.94M |
| Property, Plant & Equipment Net | 7.80M |
| Total Assets | 67.34M |
| Debt Current | 38.45K |
| Total Debt | 384.60K |
| Current Liabilities | 5.21M |
| Debt Non-Current | 346.15K |
| Total Liabilities | 5.92M |
| Accumulated Retained Earnings (Deficit) | -648.03K |
| Accumulated Other Comprehensive Income | -1.21M |
| Shareholders Equity | 61.41M |
| Shareholders Equity (USD) | 61.41M |
| Assets Non-Current | 14.40M |
| Total Debt (USD) | 384.60K |
| Deferred Revenue | 1.97M |
| Goodwill and Intangible Assets | 6.60M |
| Inventory | 14.00M |
| Liabilities Non-Current | 709.57K |
| Trade and Non-Trade Payables | 1.34M |
| Tax Liabilities | 324.96K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 324.03K |
| Net Cash Flow from Financing | -13.67K |
| Net Cash Flow / Change in Cash & Cash Equivalents | 177.97K |
| Capital Expenditure | 27.06K |
| Issuance (Purchase) of Equity Shares | -13.67K |
| Net Cash Flow from Investing | 12.39K |
| Net Cash Flow from Operations | 570.38K |
| Effect of Exchange Rate Changes on Cash | -391.12K |
| Share Based Compensation | -13.70K |